Kristin Brogaard, PhD - Balancing The Scales: Male vs Female Infertility
SALT LAKE CITY - Our own Dr. Kristin Brogaard, Chief Scientific Officer at Inherent Biosciences, attended and participated in a scintillating panel to discuss the importance of male infertility in the fertility journey.
See this LinkedIn post highlighting photos from the panel and their discussion topics: https://www.linkedin.com/posts/womens-health-innovation-series_rhis-womenshealth-innovation-activity-7032006821590499330-WlTb/
About Inherent Biosciences - Inherent Biosciences, Inc. is a biotechnology company pioneering epigenetic medicine for complex diseases. Gene dysregulation, a hallmark of complex disease, has been difficult to detect and treat, until now. The company's epigenetic platform detects dysregulation across multiple genes and related pathways to pioneer a new category of diagnostics and therapeutics that leverage epigenetics, biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility. Learn more at www.inherentbio.com or connect on LinkedIn.
About Reproductive Health Innovation Summit - Connecting industry leaders to spark innovation, investment, access, and solutions across the reproductive health spectrum. To learn more, visit www.reproductivehealthinnovationusa.com.
